当前位置: 首页 >> 检索结果
共有 6613 条符合本次的查询结果, 用时 4.6055359 秒

301. Response.

作者: Cuiqiong Dai.;Fan Wu.;Yumin Zhou.;Pixin Ran.
来源: Chest. 2025年168卷4期e128-e129页

302. Methodologic Considerations in Preserved Ratio Impaired Spirometry and Airflow Limitation Assessment.

作者: Nadia Ben Lazreg.;Mariem Abdesslem.;Helmi Ben Saad.
来源: Chest. 2025年168卷4期e127-e128页

303. Response.

作者: Hira A Awan.;Alejandro P Comellas.;Eric A Hoffman.;Joseph M Reinhardt.
来源: Chest. 2025年168卷4期e125-e126页

304. Radiomic Signatures in COPD: The Need to Integrate Eosinophilic and Autoimmune Endotypes.

作者: Ajeetha Priya Gajendiran.;Mayuri Mudgal.;Kulothungan Gunasekaran.
来源: Chest. 2025年168卷4期e125页

305. Response.

作者: Chao Liu.;Hui Xiong.;Shuyun Xu.;Liangkai Chen.
来源: Chest. 2025年168卷4期e123-e125页

306. Frailty and COPD: Emphasizing Dynamic Phenotyping and Additive Interaction for Precision Risk Assessment.

作者: Yang Liu.;Qian Li.;Ying Liu.;Ke Xu.
来源: Chest. 2025年168卷4期e122-e123页

307. Extending the Lens: Long-Term Impact of COVID-19 on COPD Management and Outcomes.

作者: Sang Hyuk Kim.;Ji-Yong Moon.;Min Gu Kang.;Jong Seung Kim.;Kyung Hoon Min.;Hyun Lee.
来源: Chest. 2025年168卷4期e121-e122页

308. Newly Onset Dyspnea During Pregnancy.

作者: Marie Vermant.;Valerie Van Ballaer.;Tine Follet.;Eveline Claeys.;Samuel De Bontridder.;Nico De Crem.;Adriana Dubbeldam.;Alexandros Kalkanis.;Laurens J De Sadeleer.;Ellen De Langhe.;Wim A Wuyts.
来源: Chest. 2025年168卷4期e115-e120页

309. Respiratory Dyskinesia With Refractory Tachypnea and Alkalosis Treated by Vesicular Monoamine Transporter 2 Inhibitor.

作者: Yue-Jing Wu.;Qian He.;Fu-Gang Luo.;Tao Li.;Wan-Jun Guo.
来源: Chest. 2025年168卷4期e111-e113页
We present the case of a 69-year-old woman with a 25-year history of psychosis, managed with risperidone, who developed refractory tachypnea and alkalosis over 2 weeks. Despite multidisciplinary evaluation, she was initially misdiagnosed with psychogenic hyperventilation. Ultimately, a diagnosis of respiratory dyskinesia (RD) was established, and substantial clinical improvement was achieved after initiation of a vesicular monoamine transporter 2 (VMAT2) inhibitor. The substantial effectiveness of this therapy was confirmed over a 7-month follow-up period, with monitoring of both clinical symptoms and arterial blood gas parameters. This case highlights the diagnostic challenges posed by RD and underscores the potential utility of VMAT2 inhibitor as a novel therapeutic option.

310. A 44-Year-Old Man With a Solitary, Slowly Enlarging Mediastinal Lesion.

作者: Vasiliki Kolokotroni.;Garyfallia Perlepe.;Angeliki Cheva.;Christoforos Foroulis.;Konstantinos I Gourgoulianis.
来源: Chest. 2025年168卷4期e107-e110页
A 44-year-old man, who does not smoke, presented for investigation of a right mediastinum lesion as revealed on a routine radiograph that was performed as a requirement of his life insurance. The patient reported no associated symptoms. He did not report shortness of breath, cough, sputum, fever, chest pain, or hemoptysis. The remaining review of symptoms was also negative for issues such as muscle weakness, weight loss, night sweats, fatigue, skin rash, and visible, palpable, or painful lymphadenopathy. His medical history was unremarkable, and he did not receive any regular medication. The patient's professional occupation was not related to special exposure and he did not report alcohol consumption, illicit drug use, or any recent travel.

311. Music in Practice.

作者: Daniel Song.
来源: Chest. 2025年168卷4期994-995页

312. Estimating Heterogeneous Treatment Effects With Target Trial Emulation: A Checklist of Causal Machine Learning for Observational Data.

作者: Xiaofeng Wang.;Yan Zou.;Yifan Wang.;Chao Zhang.
来源: Chest. 2025年168卷4期856-859页

313. Measuring What Matters: The Pseudo-Productivity Paradox in Health Care.

作者: Scott M Matson.
来源: Chest. 2025年168卷4期853-855页

314. Sleeping With the Enemy: The Hidden Burden of OSA Among Military Personnel.

作者: Peter A Cistulli.;Atul Malhotra.;Jean-Louis Pepin.
来源: Chest. 2025年168卷4期850-852页

315. Smells Like Preterm Bronchopulmonary Dysplasia: A Novel Path Forward for Predicting Prematurity-Associated Bronchopulmonary Dysplasia.

作者: Telford Yeung.;Bonny Jasani.
来源: Chest. 2025年168卷4期848-849页

316. Choosing the First Ventilator Mode in Critically Ill Patients: Set It Right, Control It Better!

作者: Damien Barrau.;Christophe Guervilly.
来源: Chest. 2025年168卷4期846-847页

317. Overpowered or Underexplored: Is Mechanical Power Causative or Reflective of Outcomes in the ICU?

作者: Sarah Wahlster.;James A Town.
来源: Chest. 2025年168卷4期843-845页

318. Corrigendum to: Costa Filho, Buckley, Furlan et al. Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States. Chest. 2025;167(2):436-443.

来源: Chest. 2025年168卷4期1072页

319. Corrigendum to: Cooper, A. The Mountain. Chest. 2024;166(1):187-189.

来源: Chest. 2025年168卷4期1072页

320. Lung Cancer Risk in Preserved Ratio Impaired Spirometry and Airway Obstruction: A UK Biobank Study.

作者: Joon Young Choi.;Chin Kook Rhee.;Jongin Lee.
来源: Chest. 2026年169卷3期837-848页
Preserved ratio impaired spirometry (PRISm) has emerged as a distinct pulmonary pattern with potential clinical significance, but its association with lung cancer risk remains unclear.
共有 6613 条符合本次的查询结果, 用时 4.6055359 秒